Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Metairie, LA
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Metairie, LA
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
New Orleans, LA
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Slidell, LA
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Slidell, LA
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Auburn, ME
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Auburn, ME
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Southfield, MI
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Southfield, MI
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
St. Louis, MO
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Lincoln, NE
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Lincoln, NE
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Omaha, NE
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Elmer, NJ
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Elmer, NJ
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Laurelton, NY
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Laurelton, NY
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Stony Brook, NY
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Wiliamsville, NY
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Wiliamsville, NY
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Durham, NC
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Durham, NC
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Marion, OH
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Marion, OH
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigational Site
mi
from
Charleston, SC
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Varnville, SC
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Varnville, SC
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Germantown, TN
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Germantown, TN
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Memphis, TN
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Nashville, TN
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Nashville, TN
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative site
mi
from
Dallas, TX
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Houston, TX
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Houston, TX
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Houston, TX
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Everett, WA
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Everett, WA
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigator Site
mi
from
Kirkland, WA
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigator Site
mi
from
Kirkland, WA
Click here to add this to my saved trials
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated:  4/7/2016
Novartis Investigative Site
mi
from
Bahia Blanca,
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Status: Enrolling
Updated: 4/7/2016
Novartis Investigative Site
mi
from
Bahia Blanca,
Click here to add this to my saved trials
Alternative Sensory Presentation Formats in Asymptomatic Carotid Stenosis
A Randomized Trial of Alternative Sensory Presentation Formats in Asymptomatic Carotid Stenosis
Status: Enrolling
Updated:  4/7/2016
Rhode Island Hospital
mi
from
Providence, RI
Alternative Sensory Presentation Formats in Asymptomatic Carotid Stenosis
A Randomized Trial of Alternative Sensory Presentation Formats in Asymptomatic Carotid Stenosis
Status: Enrolling
Updated: 4/7/2016
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Pilot Study of the CoVa™ Monitoring of Patients With Congestive Heart Failure
Pilot Study of the CoVa™ Monitoring of Patients With Congestive Heart Failure
Status: Enrolling
Updated:  4/7/2016
Scripps Health
mi
from
San Diego, CA
Pilot Study of the CoVa™ Monitoring of Patients With Congestive Heart Failure
Pilot Study of the CoVa™ Monitoring of Patients With Congestive Heart Failure
Status: Enrolling
Updated: 4/7/2016
Scripps Health
mi
from
San Diego, CA
Click here to add this to my saved trials
Characterization of Adipose Derived Regenerative Cells (ADRCs) From Patients With Chronic Heart Disease
Characterization of Adipose Derived Regenerative Cells (ADRCs) From Excess Tissue and Cells Designated for Discard From Patients With Chronic Heart Disease
Status: Enrolling
Updated:  4/7/2016
Scripps Clinic - Torrey Pines, Scripps Green Hospital
mi
from
La Jolla, CA
Characterization of Adipose Derived Regenerative Cells (ADRCs) From Patients With Chronic Heart Disease
Characterization of Adipose Derived Regenerative Cells (ADRCs) From Excess Tissue and Cells Designated for Discard From Patients With Chronic Heart Disease
Status: Enrolling
Updated: 4/7/2016
Scripps Clinic - Torrey Pines, Scripps Green Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
Characterization of Adipose Derived Regenerative Cells (ADRCs) From Patients With Chronic Heart Disease
Characterization of Adipose Derived Regenerative Cells (ADRCs) From Excess Tissue and Cells Designated for Discard From Patients With Chronic Heart Disease
Status: Enrolling
Updated:  4/7/2016
University of Florida
mi
from
Gainesville, FL
Characterization of Adipose Derived Regenerative Cells (ADRCs) From Patients With Chronic Heart Disease
Characterization of Adipose Derived Regenerative Cells (ADRCs) From Excess Tissue and Cells Designated for Discard From Patients With Chronic Heart Disease
Status: Enrolling
Updated: 4/7/2016
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Characterization of Adipose Derived Regenerative Cells (ADRCs) From Patients With Chronic Heart Disease
Characterization of Adipose Derived Regenerative Cells (ADRCs) From Excess Tissue and Cells Designated for Discard From Patients With Chronic Heart Disease
Status: Enrolling
Updated:  4/7/2016
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Characterization of Adipose Derived Regenerative Cells (ADRCs) From Patients With Chronic Heart Disease
Characterization of Adipose Derived Regenerative Cells (ADRCs) From Excess Tissue and Cells Designated for Discard From Patients With Chronic Heart Disease
Status: Enrolling
Updated: 4/7/2016
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Characterization of Adipose Derived Regenerative Cells (ADRCs) From Patients With Chronic Heart Disease
Characterization of Adipose Derived Regenerative Cells (ADRCs) From Excess Tissue and Cells Designated for Discard From Patients With Chronic Heart Disease
Status: Enrolling
Updated:  4/7/2016
Texas Heart Institute
mi
from
Houston, TX
Characterization of Adipose Derived Regenerative Cells (ADRCs) From Patients With Chronic Heart Disease
Characterization of Adipose Derived Regenerative Cells (ADRCs) From Excess Tissue and Cells Designated for Discard From Patients With Chronic Heart Disease
Status: Enrolling
Updated: 4/7/2016
Texas Heart Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Researching Emotions And Cardiac Health
Developing a Positive Psychology Intervention to Promote Health Behaviors in Heart Failure: Qualitative Research Phase
Status: Enrolling
Updated:  4/8/2016
Massachusetts General Hospital
mi
from
Boston, MA
Researching Emotions And Cardiac Health
Developing a Positive Psychology Intervention to Promote Health Behaviors in Heart Failure: Qualitative Research Phase
Status: Enrolling
Updated: 4/8/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
NIRS Predict Low Cardiac Output State in Neonates and Infants in Cardiac Surgery
Does Near Infrared Spectroscopy Predict Low Cardiac Output State in Neonates and Infants Following Cardiac Surgery for Congenital Heart Disease?
Status: Enrolling
Updated:  4/11/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
NIRS Predict Low Cardiac Output State in Neonates and Infants in Cardiac Surgery
Does Near Infrared Spectroscopy Predict Low Cardiac Output State in Neonates and Infants Following Cardiac Surgery for Congenital Heart Disease?
Status: Enrolling
Updated: 4/11/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Peter Morton UCLA Medical Center
mi
from
Los Angeles, CA
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Peter Morton UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Florida Hospital
mi
from
Orlando, FL
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Massachusetts General Hospital
mi
from
Boston, MA
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
University of Michigan Medical Center
mi
from
Ann Arbor, MI
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
University of Michigan Medical Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
McLaren Regional Medical Center
mi
from
Flint, MI
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
McLaren Regional Medical Center
mi
from
Flint, MI
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Albany Medical Center
mi
from
Albany, NY
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Albany Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
University at Buffalo Neurosurgery
mi
from
Buffalo, NY
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
University at Buffalo Neurosurgery
mi
from
Buffalo, NY
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Columbia University
mi
from
New York, NY
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
University Hospitals Case Medical Center and Case Western Reserve University School of Medicine
mi
from
Cleveland, OH
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
University Hospitals Case Medical Center and Case Western Reserve University School of Medicine
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Riverside Methodist Hospital
mi
from
Columbus, OH
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Jobst Vascular Institute
mi
from
Toledo, OH
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Jobst Vascular Institute
mi
from
Toledo, OH
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Oklahoma Heart
mi
from
Oklahoma City, OK
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Oklahoma Heart
mi
from
Oklahoma City, OK
Click here to add this to my saved trials